| Megan H Taylor, | |
|
955 Ribaut Rd, Beaufort, SC 29902-5441 | |
| (803) 454-2600 | |
| (803) 765-1732 |
| Full Name | Megan H Taylor |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 21 Years |
| Location | 955 Ribaut Rd, Beaufort, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649249863 | NPI | - | NPPES |
| AN1260 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1218 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Coastal Carolina Hospital | Hardeeville, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstream Anesthesia Pllc | 7416198049 | 566 |
News Archive
Celerion, the premier provider of innovative early stage clinical research solutions, announces the launch of a new Hybrid Phase I/ ECG Core lab. The Hybrid Phase I/ ECG Core lab provides highly automated ECG analysis for Celerion's global Phase I clinical network. Celerion's highly automated approach employs cutting-edge technology to perform automated measurement of ECG recordings, thereby minimizing cardiologist review and providing clients with faster access to data.
Poor diets are the now the leading risk factor for the global burden of disease, accounting for one-fifth of all deaths worldwide. While the causes of poor diets are complex, new research finds the affordability of more nutritious foods is an important factor.
Researchers at Johns Hopkins have shown that using specific drugs can protect nerve cells in mice from the lethal effects of Parkinson's disease. The researchers' findings are published in the August 22 issue of Nature Medicine.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, today announced the closing of the first tranche of a private placement resulting in the issue of 400,000 Units at a price of $0.35 per Unit.
› Verified 9 days ago
| Entity Name | Low Country Anesthesia, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417928268 PECOS PAC ID: 8729063797 Enrollment ID: O20040623000371 |
News Archive
Celerion, the premier provider of innovative early stage clinical research solutions, announces the launch of a new Hybrid Phase I/ ECG Core lab. The Hybrid Phase I/ ECG Core lab provides highly automated ECG analysis for Celerion's global Phase I clinical network. Celerion's highly automated approach employs cutting-edge technology to perform automated measurement of ECG recordings, thereby minimizing cardiologist review and providing clients with faster access to data.
Poor diets are the now the leading risk factor for the global burden of disease, accounting for one-fifth of all deaths worldwide. While the causes of poor diets are complex, new research finds the affordability of more nutritious foods is an important factor.
Researchers at Johns Hopkins have shown that using specific drugs can protect nerve cells in mice from the lethal effects of Parkinson's disease. The researchers' findings are published in the August 22 issue of Nature Medicine.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, today announced the closing of the first tranche of a private placement resulting in the issue of 400,000 Units at a price of $0.35 per Unit.
› Verified 9 days ago
| Entity Name | Medstream Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649616160 PECOS PAC ID: 7416198049 Enrollment ID: O20140304001021 |
News Archive
Celerion, the premier provider of innovative early stage clinical research solutions, announces the launch of a new Hybrid Phase I/ ECG Core lab. The Hybrid Phase I/ ECG Core lab provides highly automated ECG analysis for Celerion's global Phase I clinical network. Celerion's highly automated approach employs cutting-edge technology to perform automated measurement of ECG recordings, thereby minimizing cardiologist review and providing clients with faster access to data.
Poor diets are the now the leading risk factor for the global burden of disease, accounting for one-fifth of all deaths worldwide. While the causes of poor diets are complex, new research finds the affordability of more nutritious foods is an important factor.
Researchers at Johns Hopkins have shown that using specific drugs can protect nerve cells in mice from the lethal effects of Parkinson's disease. The researchers' findings are published in the August 22 issue of Nature Medicine.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, today announced the closing of the first tranche of a private placement resulting in the issue of 400,000 Units at a price of $0.35 per Unit.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Megan H Taylor, Po Box 1927, Columbia, SC 29202-1927 Ph: (803) 765-1838 | Megan H Taylor, 955 Ribaut Rd, Beaufort, SC 29902-5441 Ph: (803) 454-2600 |
News Archive
Celerion, the premier provider of innovative early stage clinical research solutions, announces the launch of a new Hybrid Phase I/ ECG Core lab. The Hybrid Phase I/ ECG Core lab provides highly automated ECG analysis for Celerion's global Phase I clinical network. Celerion's highly automated approach employs cutting-edge technology to perform automated measurement of ECG recordings, thereby minimizing cardiologist review and providing clients with faster access to data.
Poor diets are the now the leading risk factor for the global burden of disease, accounting for one-fifth of all deaths worldwide. While the causes of poor diets are complex, new research finds the affordability of more nutritious foods is an important factor.
Researchers at Johns Hopkins have shown that using specific drugs can protect nerve cells in mice from the lethal effects of Parkinson's disease. The researchers' findings are published in the August 22 issue of Nature Medicine.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, today announced the closing of the first tranche of a private placement resulting in the issue of 400,000 Units at a price of $0.35 per Unit.
› Verified 9 days ago
Michael James Davidson, RN Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1 Pinckney Blvd, Beaufort, SC 29902 Phone: 843-228-5994 | |
Kathy Tines Becker, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1 Pinckney Blvd, Naval Hospital Beaufort, Beaufort, SC 29902 Phone: 843-228-5200 Fax: 843-228-5300 | |
Kenneth C. Evec, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 955 Ribaut Rd, Beaufort, SC 29902 Phone: 803-454-2600 Fax: 803-765-1732 | |
Brenda G. Leming, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 955 Ribaut Road, Beaufort, SC 29902 Phone: 803-454-2600 Fax: 803-765-1732 | |
Robert H. Copeland, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 955 Ribaut Road, Beaufort, SC 29902 Phone: 803-454-2613 Fax: 803-765-1732 | |
Patricia A. Irvine, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 955 Ribaut Rd, Beaufort, SC 29902 Phone: 803-454-2600 Fax: 803-765-1732 | |
Cynthia S. Crowther, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 955 Ribaut Rd, Beaufort, SC 29902 Phone: 803-454-2600 Fax: 803-765-1732 |